FORESIGHT VCT PLC
• Total net assets £136.7 million.
• A final dividend of 3.3p per share was paid on 19 June 2020, costing £6.8 million.
• The portfolio has seen a decrease in valuation of £13.2 million in the last six months.
• Net Asset Value per share decreased by 14.0% from 76.5p at 31 December 2019 to 65.8p at 30 June 2020. Including the payment of a 3.3p dividend made on 19 June 2020, NAV total return per share was 69.1p, representing a decrease in total return of 9.7%.
• The offer for subscription launched in January 2020 was closed on 7 April 2020 and raised a total of £24.8 million before expenses.
I am pleased to present the Company’s Unaudited Half- Yearly Financial Report for the period ended 30 June 2020.
MATERIAL EVENTS DURING THE PERIOD
Before providing other details, I would like to draw attention to the two material events that have occurred during the period. The first is the continuing impact of Covid-19 on the Company and its portfolio and the second is the Company’s fundraising which closed on 7 April this year.
The Covid-19 virus has presented the Company and the management of every one of its portfolio companies with unprecedented challenges which it is anticipated will persist for a considerable time to come. The Manager has been working closely with the portfolio companies, in order to try to minimise any adverse impact of this virus, and it is a great credit to the quality of the management of the portfolio companies, that the fallout from the pandemic has not been even more significant. Until this virus is brought under worldwide control, it is impossible to assess its full impact. However, it is already clear that the value of every business in the Company’s portfolio has been materially affected, a minority have benefitted but most have not.
At the end of last year the Company held 13 investments, representing some 22% by value of its investment portfolio, in businesses involved in the travel, retail, entertainment and food and drink sectors. To date these sectors are amongst those most hard hit by the provisions of the lockdown imposed by the UK Government in response to the Covid-19 virus. I am pleased to report that since the recent easing of the lockdown provisions all the Company’s investments in these sectors are continuing to trade and, with one possible exception, they are already pursuing revised business strategies which hold the potential for a return to commercial viability in the short to medium term. It will, however, be some time before the value of most of these businesses is again at or above their pre-Covid levels.
The overall impact of the Covid virus during the first six months of this year can be seen in the material fall in the valuation of the Company’s portfolio. On a positive note, I can say that since the period end the trading position of many of these businesses has improved, some quite significantly. On behalf of the Board I would like to thank the Manager for the considerable work which it has done and is continuing to do alongside the management teams at each and every one of the companies within the portfolio.
At the start of this year some 90% of the Company’s assets were already invested and the Board believed it would be in the Company’s best interest to raise further funds to provide liquidity for its activities over the coming year and beyond. Despite the difficulties created by Covid-19, the Board is pleased that the Company was successful in raising additional funds to support both its current and future portfolio of investments. The Company closed its offer for subscription on 7 April and raised £24.8 million before expenses. The majority of the funds received were subscribed in the final allotments totalling £18.6 million, which took place on 3 April and 14 April based on a NAV of 66.5p per share, which compared with the NAV at the end of last year of 76.5p per share.
The Board, together with the Manager, continue to pursue a strategy for the Company which includes the following four key objectives:
• further development of the net assets of the Company to a level in excess of £150 million;
• payment of an annual dividend to shareholders of at least 5% of the NAV per share and at the same time endeavouring to maintain the NAV per share at around its current level;
• the implementation of a significant number of new and follow on qualifying investments every year; and
• maintaining a programme of regular share buy backs at a discount in the region of 10% to the prevailing NAV per share.
The Board and the Manager believe that these key objectives remain appropriate and the Company’s performance in relation to each of them over the period is reviewed more fully below.
NET ASSET VALUE
At 30 June 2020 the NAV of the Company stood at £136.7 million (31 December 2019: £133.1 million). The successful fundraising completed during the period under review added £24.2m to the NAV.
However, in the six months to 30 June 2020 the NAV per share decreased by 14.0% from 76.5p at 31 December 2019 to 65.8p at 30 June 2020. Including the payment of a 3.3p dividend made on 19 June 2020, which is detailed below, NAV total return per share was 69.1p, representing a decrease in total return of 9.7%.
The final dividend of 3.3p per share was paid on 19 June 2020 based on an ex-dividend date of 4 June 2020, with a record date of 5 June 2020. The total cost of this dividend was £6.8 million, including shares allotted under the dividend reinvestment scheme.
The total return per share from an investment made five years ago would be 3.7%, which is materially below the target return set by the Board. It is the future achievement of this target that is at the centre of the Company’s current and future portfolio management strategy.
INVESTMENT PERFORMANCE AND PORTFOLIO ACTIVITY
A detailed analysis of the investment portfolio performance over the period is given in the Manager’s Review.
The Company started the current period with nearly 90% of its assets invested in a range of unquoted growth capital investments; the Board and the Manager believe that despite recent events more fully described above, the majority of these investments will continue to mature and help improve the future rate of growth in NAV. During the period under review the Manager made no new investments, as it focused on supporting the current portfolio during the ongoing Covid-19 Coronavirus outbreak.
The Company and Foresight 4 VCT plc have the same Manager and share similar investment policies. The Board closely monitors the extent and nature of the pipeline of investment opportunities and is reassured by the Manager’s confidence in being able to deploy funds without compromising quality during 2020 and beyond, so as to be in a position to satisfy the investment needs of both companies. We do however anticipate that the impact of Covid-19 will continue to slow down the new investment process and will delay at least some of the anticipated realisation dates of existing investments.
During the period the Company repurchased 2.4 million shares for cancellation at an average discount of 9.9%. The Board and the Manager consider that the ability to offer to buy back shares at a target discount of approximately 10% is fair to both continuing and selling shareholders and is an appropriate way to help underpin the discount to NAV at which the shares trade. Share buybacks are timed to avoid the Company’s closed periods and will usually take place, subject to demand, during the following times of year:
• April, after the Annual Report has been published;
• June, prior to the Half-Yearly reporting date of 30 June;
• September, after the Half-Yearly Report has been published; and
• December, prior to the end of the financial year.
MANAGEMENT CHARGES, CO-INVESTMENT AND INCENTIVE ARRANGEMENTS
The annual management fee is an amount equal to 2.0% of net assets, excluding cash balances above £20 million, which are charged at a reduced rate of 1.0%. With the unforeseen impact of Covid-19, this has resulted in an ongoing charges ratio for the period ended 30 June 2020 of 2.4% of net assets, which is within the 2.4% cap. In line with the Management Agreement, any rebate for expenses above the expense cap will be assessed at the year end.
Since March 2017, co-investments made by the Manager and individual members of the Manager’s private equity team have totalled £0.7 million alongside the Company’s investments of £48.1 million. Under the terms of the Incentive Arrangements, the ‘Total NAV Return Hurdle’ has not yet been achieved and no performance incentive payment is due.
Recognising the importance of protecting shareholder interests the Board and the Manager agreed that it was appropriate to update the Incentive Arrangements and from 27 January 2020 a change to provide for an annual increase to the Total Return Hurdle (originally 100p) by the greater of RPI or 3.5% was added to the requirements.
The Board continues to review its own performance and undertakes succession planning to maintain an appropriate level of independence, experience, diversity and skills in order to be in a position to discharge all its responsibilities. It is not the present intention to alter the composition of the Board during the current year, however the Nomination Committee is embarking on the process of seeking a new non-executive director for appointment during 2021 and details will be communicated as and when appropriate.
As a result of the travel restrictions imposed due to Covid-19, the Manager’s popular investor forums have been temporarily put on hold. Once it is possible to do so, details of both a London event and regional events will be sent to shareholders resident in the locality as and when they are organised. The Manager held an investor webinar on 25 August 2020, details of which had been previously communicated to investors. It is the intention of the Manager to continue to hold investor webinars whilst the investor forums are on hold and details of any future events will be communicated to investors.
The persisting uncertainty over the full impact of Covid-19 and the negotiations in relation to Brexit create truly exceptional challenges for every business. The Company invests primarily in developing companies which by their nature benefit from general economic growth and the current environment places considerable demands upon them and their management teams. The Manager’s private equity team is well aware of the management and business needs of each of the companies within the investment portfolio and is working closely with them to help them progress during these testing times. Until the pandemic is brought under worldwide control there will inevitably be further, mainly unhelpful, implications for many UK based businesses. Notwithstanding this, the Board and the Manager have been impressed by the resilience shown by the significant majority of the Company’s investments and are optimistic that the existing portfolio has potential to add value once the virus has been successfully contained.
Telephone 01296 682751
4 September 2020
The Company has appointed Foresight Group LLP (“the Manager”) to provide investment management and administration services.
The investment management and administration arrangements were previously with Foresight Group CI Limited (the Manager’s parent undertaking), with Foresight Group CI Limited appointing the Manager as its investment adviser and delegating administration services to the Manager. The investment management and administration arrangements were novated and amended to be directly with the Manager on 27 January 2020. References to the Manager’s activities in this report include those activities of Foresight Group CI Limited prior to the change in arrangements.
As at 30 June 2020 the Company’s portfolio comprised 44 investments with a total cost of £91.2 million and a valuation of £107.1 million. The portfolio is diversified by sector, transaction type and maturity profile. Details of the ten largest investments by valuation, including an update on their performance, are provided on pages 10 to 14.
During the period, the value of unquoted investments reduced overall by £13.2 million as the portfolio was buffeted by the challenging circumstances of COVID-19. In the quarter to March the portfolio value reduced by £18.9 million, reflecting significant economic and market uncertainty as the UK entered lockdown. In the second quarter the portfolio value saw some recovery, increasing by £5.7 million, as many of the portfolio companies successfully navigated the period and economic and public market uncertainty reduced partially.
In line with the Board’s strategic objectives, the investment team remain focused on growing NAV to £150.0 million whilst paying an annual dividend to shareholders of at least 5% of the NAV per share and maintaining the capital value of NAV per share. The Company is behind on these targets currently but is working towards achieving these objectives in the medium term.
The Company has made no new investments in the six months to 30 June 2020 given the challenges of consummating a new investment during lockdown and the difficulties experienced during the period, with smaller companies focused largely on survival rather than strategic growth. In addition, the investment team was focused heavily on managing and supporting the existing portfolio through these unprecedented times.
FOLLOW ON INVESTMENTS
There have been no follow-on investments during the six months to 30 June 2020. Given the current climate, we had anticipated an increase in follow-on investments during the period. However, the portfolio has remained resilient thanks to the support and expertise of the investment team which has provided assistance and guidance throughout the COVID-19 pandemic. Many of the portfolio benefitted from various forms of Government support such as the furlough scheme and the Coronavirus Business Interruption Loan Scheme, which reduced the need for equity follow on in the period. However, as these schemes unwind and the economic climate remains depressed, we anticipate various requirements for follow-on investment.
EXITS AND REALISATIONS
In the six months to 30 June 2020 there has been one loan repayment from The Naked Deli Ltd of £0.2 million. Whilst the mergers and acquisitions climate has been challenging in the period, with most trade acquirers focused on survival and private equity investors focused on their existing portfolios or on distressed acquisitions, the Manager is seeing acquisition interest returning, particularly in the healthcare, technology and e-commerce sectors.
At 30 June 2020, the Company had cash balances of £29.1 million, which will be used to fund new and follow-on investments, buybacks and running expenses. We are seeing a recovery in the pipeline of potential investments and have a number of opportunities under exclusivity or in due diligence. The Company remains well positioned to continue pursuing these potential investment opportunities.
The onset of COVID-19 and the resulting economic downturn has resulted in minimal new investment activity in the first half of 2020. Depending on the length and severity of the COVID-19 outbreak and associated restrictions, we expect to see a higher proportion of the Company’s deployment focused on follow-on investments in the short to medium term.
As the economy recovers from the worst effects of the virus, we expect company valuations to be more attractive and demand for funding to increase, driving some particularly interesting opportunities for investment.
KEY PORTFOLIO DEVELOPMENTS
Overall, the value of investments held decreased by £13.2 million to £107.1 million in the period. A disciplined approach to investment valuations has been maintained in light of COVID-19. As stated above, in the quarter to March, the onset of the pandemic drove significant economic uncertainty and the portfolio saw a substantial decrease in value of £18.9 million. In the second quarter, as the portfolio adapted to the new economic climate, fair values saw some recovery across the board increasing by £5.7 million. Material changes in valuation, defined as increasing or decreasing by £1.0 million or more since 31 December 2019, are detailed below. Updates on these companies are included below.
|Company||Valuation (£)||Valuation Change (£)|
|Hospital Services Group Limited||5,826,846||2,193,727|
|The Naked Deli Ltd||-||(1,027,922)|
|Cinelabs International Limited||1,263,030||(1,222,341)|
|Datapath Group Limited||7,189,645||(1,235,973)|
|TFC Europe Limited||3,930,229||(1,676,434)|
|Ixaris Group Holdings Limited||1,848,696||(3,738,112)|
HOSPITAL SERVICES GROUP LIMITED
Hospital Services Group has performed exceptionally well during the first half of 2020, already eclipsing prior year’s revenue and EBITDA. This has been driven by significant sales of PPE in response to COVID-19. With a customer base and supply chain now in place, Hospital Services Group will continue to provide PPE for the foreseeable future. The company’s core business divisions have continued to perform well during the period.
THE NAKED DELI LTD
The Naked Deli is a healthy eating food chain predominantly targeting lunchtime trade. Prior to COVID-19, the business implemented a turnaround plan with a new CEO and a revised menu. This was showing some positive results and the business paid £280,000 of accumulated interest and loan note principal to the Company. However, The Naked Deli closed all its stores in line with government guidance in March and the outlook for this sector remains extremely challenging. There is uncertainty about town centre footfall, particularly for lunchtime trade, while employees are still working from home. Due to the difficult outlook as well as the remaining uncertainty around the business model, the investment valuation has been written down to zero pending improved visibility on re-opening performance and recovery of the sector.
CINELABS INTERNATIONAL LIMITED
Cinelabs provides non-creative post-production services to film and TV production houses globally, primarily to those shooting on analogue film. The business was trading reasonably well prior to the COVID-19 outbreak, however the complete halt of new film and TV production since lockdown has drastically impacted revenues. At the time of writing, film and TV productions were recommencing, providing some opportunity for recovery.
DATAPATH GROUP LIMITED
Prior to the outbreak of COVID-19, Datapath continued to generate material profits, helped by an improved gross margin. The company has invested in new product development and its sales channels over recent years, notably strengthening its worldwide sales team. Whilst COVID-19 has created some short-term volatility, the company has still outperformed its revised budgets.
Spektrix is an enterprise software company, providing ticketing, CRM, marketing, and fundraising software to companies in the performing arts sector in the UK and US. With theatres in the UK and US closed since March, the company has seen a reduction in revenue as part of the company’s revenues are derived from ticket sales. However, the company has continued to win new clients in the period, particularly within the UK. The UK Government’s recently announcement support package for the UK arts industry should improve trading and a number of theatres are now selling tickets for outdoor performances. The company has continued to invest in its technology, increasing functionality, resilience and scalability during the period.
TFC EUROPE LIMITED
TFC Europe is one of Europe’s leading suppliers of fixing and fastening products to customers across a wide range of industries, including aerospace, automotive, oil & gas and mechanical engineering. The business has remained profitable during the period, however revenues are down 35% on prior year. TFC has used this period to review its pricing model and overall strategy to increase value in the long-term.
IXARIS GROUP HOLDINGS LIMITED
Ixaris is a payments platform enabling efficient global payments, targeting the travel sector in particular. Ixaris had a strong financial year to December 2019 but has since seen a severe downturn in trading due to the disruption faced by the travel sector in the wake of the pandemic. The business is fundamentally strong and there is clear potential for value recovery. The team have used this opportunity to refine the current business model and look for areas for improvement.
We reacted quickly to the onset of COVID-19 in March 2020, working closely with the portfolio companies to identify risk areas and encourage businesses to take the necessary actions and precautions. As more businesses begin to reopen, the trading landscape looks very different and companies are having to adapt to a ‘new normal’. We are supporting the portfolio companies through this process, working closely with them to implement safe working environments and resilient business models.
A proportion of the portfolio companies are particularly at risk due to the sectors they operate in, such as travel, hospitality and leisure. We are working extensively with these businesses, paying particular attention to managing creditors and cash preservation. The Government has now allowed pubs, restaurants and bars to reopen, adhering to a strict set of health and safety measures. The sector remains at risk with indoor hospitality settings having to reduce capacity by 50% on average, combined with reduced consumer appetite to visit bars or restaurants. Nevertheless, some of the Company’s leisure investments demonstrated market leading site metrics pre-COVID and will have the ability to weather this temporary period of reduced trading. Even with capacity limitations, we expect several of our leisure businesses to return to profit and cash generation over time thanks to a loyal customer base and young demographic.
There are also a number of companies, namely in the healthcare and life sciences sectors, which have traded strongly during this period due to the increased demand for the services they offer. Examples of this include Mologic, which recently received a grant of c.£1 million to fund COVID-related diagnostic development. Molecular diagnostics business, Biofortuna has also been presented with a number of opportunities to help manufacture COVID-19 test kits and they have manufactured 17 million test kits to date. They will also explore further commercial possibilities in the space. Another of the portfolio companies, Hospital Services Group, has seen increased demand for mobile x-ray machines, as chest x-rays are part of the treatment pathway for COVID-19.
As businesses reopen, we are ensuring that finance directors at the portfolio companies continue to manage overheads tightly, reduce capital expenditure and work through longer-term cost reduction plans given the uncertain macro environment. It is important that management teams and investors are well prepared for a sustained period of weaker consumer and business demand and missed forecasts as consumers and businesses adapt to the changed environment. The Company’s portfolio is diversified by sector and market, and the SME sector has historically proven to be resilient and nimble enough to weather periods of volatility.
Notwithstanding this difficult backdrop, we continue to see encouraging levels of activity from smaller UK companies seeking growth capital and expect this to increase as companies begin to recover from the impact of COVID-19 with requirements for permanent funding of working capital. VCTs are still viewed by many entrepreneurs as an attractive source of capital that provides scale-up funding to businesses at an early stage of their growth, when other sources of funding may not be readily available or alongside other sources of funding, including the government measures for supporting businesses during COVID-19. Despite the current challenges of COVID-19 in the medium and long term, the UK remains an excellent place to start, scale and sell a business, with broad pools of talent and an entrepreneurial culture.
Head of Private Equity
4 September 2020
Unaudited Half-Yearly Results and Responsibilities Statements
Principal Risks and Uncertainties
The principal risks faced by the Company are as follows:
- Operational; and
The Board reported on the principal risks and uncertainties faced by the Company in the Annual Report and Accounts for the year ended 31 December 2019. A detailed explanation can be found on page 27 of the Annual Report and Accounts which is available on the Company’s website www.foresightvct.com or by writing to Foresight Group at The Shard, 32 London Bridge Street, London, SE1 9SG.
In the view of the Board, there have been no changes to the fundamental nature of these risks since the previous report and these principal risks and uncertainties are equally applicable to the remaining six months of the financial year as they were to the six months under review.
DIRECTORS’ RESPONSIBILITY STATEMENT
The Disclosure and Transparency Rules (‘DTR’) of the UK Listing Authority require the Directors to confirm their responsibilities in relation to the preparation and publication of the Interim Report and financial statements.
The Directors confirm to the best of their knowledge that:
- the summarised set of financial statements has been prepared in accordance with FRS 104;
- the interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year);
- the summarised set of financial statements gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company as required by DTR 4.2.4R; and
- the interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties’ transactions and changes therein).
The Company’s business activities, together with the factors likely to affect its future development, performance and position, are set out in the Strategic Report of the Annual Report. The financial position of the Company, its cash flows, liquidity position and borrowing facilities are described in the Chairman’s Statement, Strategic Report and Notes to the Accounts of the 31 December 2019 Annual Report. In addition, the Annual Report includes the Company’s objectives, policies and processes for managing its capital; its financial risk management objectives; details of its financial instruments; and its exposures to credit risk and liquidity risk.
The Company has considerable financial resources together with investments and income generated therefrom across a variety of industries and sectors. As a consequence, the Directors believe that the Company is well placed to manage its business risks successfully.
The Directors have reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.
The Half-Yearly Financial Report has not been audited nor reviewed by the auditors.
On behalf of the Board
4 September 2020
Unaudited Income Statement
for the six months ended 30 June 2020
|Six months ended 30 June 2020 (Unaudited)||Six months ended 30 June 2019 (Unaudited)||Year ended 31 December 2019 (Audited)|
|Revenue £’000||Capital £’000||Total £’000||Revenue £’000||Capital £’000||Total £’000||Revenue £’000||Capital £’000||Total £’000|
|Realised gains/(losses) on investments||-||13||13||-||(3,341)||(3,341)||-||(2,551)||(2,551)|
|Investment holding (losses)/ gains||-||(13,227)||(13,227)||-||8,204||8,204||-||10,258||10,258|
|Investment management fees||(353)||(1,057)||(1,410)||(314)||(943)||(1,257)||(643)||(1,930)||(2,573)|
|Return/ (loss) on ordinary activities before taxation||1,378||(14,271)||(12,893)||74||3,920||3,994||76||5,777||5,853|
|Return/ (loss) on ordinary activities after taxation||1,378||(14,271)||(12,893)||74||3,920||3,994||76||5,777||5,853|
|Return/ (loss) per share:|
The total column of this statement is the profit and loss account of the Company and the revenue and capital columns represent supplementary information.
All revenue and capital items in the above Income Statement are derived from continuing operations. No operations were acquired or discontinued in the period.
The Company has no recognised gains or losses other than those shown above, therefore no separate statement of total recognised gains and losses has been presented.
The Company has only one class of business and one reportable segment, the results of which are set out in the Income Statement and Balance Sheet.
There are no potentially dilutive capital instruments in issue and, therefore, no diluted earnings per share figures are relevant. The basic and diluted earnings per share are, therefore, identical.
Unaudited Balance Sheet
at 30 June 2020
Registered Number: 03421340
| As at |
30 June 2020 £’000
| As at |
30 June 2019 £’000
| As at |
31 December 2019
|Investments held at fair value through profit or loss||107,118||112,774||120,521|
|Cash and cash equivalents||29,079||19,810||12,324|
|Amounts falling due within one year||(290)||(479)||(88)|
|Net current assets||29,586||19,566||12,598|
|Capital and reserves|
|Called-up share capital||2,078||1,755||1,740|
|Share premium account||103,319||100,495||78,841|
|Capital redemption reserve||975||935||951|
|Equity shareholders’ funds||136,704||132,340||133,119|
|Net asset value per share:|
Unaudited Reconciliation of Movements in Shareholders' Funds
for the six months ended 30 June 2020
| Called-up share capital |
| Share premium account |
| Capital redemption reserve |
| Distributable reserve^ |
| Capital reserve^ |
| Revaluation reserve |
| Total |
|As at 1 January 2020||1,740||78,841||951||23,799||(1,059)||28,847||133,119|
|Share issues in the period||362||25,655||-||-||-||-||26,017|
|Expenses in relation to share issues||-||(1,177)||-||-||-||-||(1,177)|
|Repurchase of shares||(24)||-||24||(1,558)||-||-||(1,558)|
|Realised gains on disposal of investments||-||-||-||-||13||-||13|
|Investment holding losses||-||-||-||-||-||(13,227)||(13,227)|
|Management fees charged to capital||-||-||-||-||(1,057)||-||(1,057)|
|Revenue return for the period||-||-||-||1,378||-||-||1,378|
|As at 30 June 2020||2,078||103,319||975||16,815||(2,103)||15,620||136,704|
^Reserve is available for distribution, total distributable reserves at 30 June 2020 total £14,712,000 (31 December 2019: £22,740,000).
Unaudited Cash Flow Statement
for the six months ended 30 June 2020
| Six months ended 30 June 2020 |
| Six months ended 30 June 2019 |
| Year ended 31 December 2019 |
|Cash flow from operating activities|
|Loan interest received from investments||230||381||733|
|Dividends received from investments||1,437||113||178|
|Deposit and similar interest received||29||107||186|
|Investment management fees paid||(1,364)||(1,257)||(2,573)|
|Secretarial fees paid||(60)||(62)||(122)|
|Other cash payments||(312)||(257)||(465)|
|Net cash outflow from operating activities||(40)||(975)||(2,063)|
|Cash flow from investing activities|
|Purchase of investments||-||(8,956)||(15,791)|
|Net proceeds on sale of investments||188||45||1,966|
|Net proceeds on deferred consideration||13||441||441|
|Net cash inflow /(outflow) from investing activities||201||(8,470)||(13,384)|
|Cash flow from financing activities|
|Proceeds of fund raising||24,203||-||-|
|Expenses of fund raising||(594)||(46)||(92)|
|Repurchase of own shares||(1,442)||(810)||(2,248)|
|Net cash inflow/ (outflow) from financing activities||16,594||(8,164)||(9,648)|
|Net inflow/ (outflow) of cash in the period||16,755||(17,609)||(25,095)|
|Reconciliation of net cash flow to movement in net funds|
|Increase/ (decrease) in cash and cash equivalents for the period||16,755||(17,609)||(25,095)|
|Net cash and cash equivalents at the start of period||12,324||37,419||37,419|
|Net cash and cash equivalents at the end of period||29,079||19,810||12,324|
Analysis of changes in net debt
| At 1 January 2020 |
| Cash Flow |
| At 30 June 2020 |
|Cash and cash equivalents||12,324||16,755||29,079|
Notes to the Unaudited Half-Yearly Results
- The Unaudited Half-Yearly Financial Report has been prepared on the basis of the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2019. Unquoted investments have been valued in accordance with IPEV Valuation Guidelines.
- These are not statutory accounts in accordance with S436 of the Companies Act 2006 and the financial information for the six months ended 30 June 2020 and 30 June 2019 has been neither audited nor formally reviewed. Statutory accounts in respect of the year ended 31 December 2019 have been audited and reported on by the Company's auditors and delivered to the Registrar of Companies and included the report of the auditors which was unqualified and did not contain a statement under S498(2) or S498(3) of the Companies Act 2006. No statutory accounts in respect of any period after 31 December 2019 have been reported on by the Company's auditors or delivered to the Registrar of Companies.
- Copies of the Unaudited Half-Yearly Financial Report will be sent to shareholders via their chosen method and will be available for inspection at the Registered Office of the Company at The Shard, 32 London Bridge Street, London, SE1 9SG.
- Net asset value per share
The net asset value per share is based on net assets at the end of the period and on the number of shares in issue at the date.
| Net assets ||Number of Shares in Issue|
|30 June 2020||£136,704,000||207,824,856|
|30 June 2019||£132,340,000||175,481,093|
|31 December 2019||£133,119,000||173,959,405|
- Return per share
The weighted average number of shares used to calculate the respective returns are shown in the table below.
|Six months ended 30 June 2020||191,020,332|
|Six months ended 30 June 2019||175,365,523|
|Year ended 31 December 2019||175,090,865|
Earnings for the period should not be taken as a guide to the results for the full year.
| Six months ended 30 June 2020 |
| Six months ended 30 June 2019 |
| Year ended 31 December 2019 |
|Loan stock interest||548||457||920|
|Deposit and similar interest received||29||107||186|
7) Investments at fair value through profit or loss
|Book cost as at 1 January 2020||91,360|
|Investment holding gains||29,161|
|Valuation at 1 January 2020||120,521|
|Movements in the period:|
|Investment holding gains**||(13,215)|
|Valuation at 30 June 2020||107,118|
|Book cost at 30 June 2020||91,172|
|Investment holding gains||15,946|
|Valuation at 30 June 2020||107,118|
*Realised gains in the income statement relate to deferred consideration of £13,000 received from the sale of Idio Limited.
**Investment holding losses in the income statement include the removal of the deferred consideration debtor of £12,000, relating to Idio Limited.
8) Related party transactions
No Director has an interest in any contract to which the Company is a party other than their appointment and payment as directors.
9) Transactions with the Manager
Foresight Group CI Limited, which acted as Manager to the Company until 27 January 2020, earned fees of £192,000 (30 June 2019: £1,257,000, 31 December 2019: £2,573,000). Foresight Group LLP was appointed as Manager on 27 January 2020 and earned fees of £1,218,000 up to 30 June 2020 (30 June 2019: £nil, 31 December 2019: £nil).
Foresight Group LLP is the Company Secretary (appointed in November 2017) and received, directly and indirectly, for accounting and company secretarial services fees of £60,000 (30 June 2019: £60,000, 31 December 2019: £120,000) during the period.
At the balance sheet date there was £nil (30 June 2019: £nil, 31 December 2019: £nil) due to Foresight Group CI Limited and £7,000 (30 June 2019: £nil, 31 December 2019: £nil) due to Foresight Group LLP.